Chronic heart failure treatment, Inspra (eplerenone), accepted for use within ... News-Medical.net Inspra (eplerenone) has now been accepted by the All Wales Medicines Strategy Group (AWMSG) for use in adult patients with chronic heart failure (CHF) NYHA class II, in combination with standard optimal therapy,(1) following evidence to support its ... |
